Viridian Therapeutics, Inc. VRDN Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s accrued manufacturing costs?
- Viridian Therapeutics, Inc. (VRDN) reported accrued manufacturing costs of $8.36M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s accrued manufacturing costs changed year-over-year?
- Viridian Therapeutics, Inc.'s accrued manufacturing costs increased by 64.1% year-over-year, from $5.1M to $8.36M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s accrued manufacturing costs?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s accrued manufacturing costs has grown at a 58.5% compound annual growth rate (CAGR), from $1.96M to $19.66M.